Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
Congo begins trial of Gilead's obeldesivir for Ebola Bundibugyo as outbreak worsens
00

Congo begins trial of Gilead's obeldesivir for Ebola Bundibugyo as outbreak worsens

Jul 14, 2026

Congo has begun a clinical trial for Gilead's experimental drug obeldesivir to combat a worsening Ebola Bundibugyo outbreak that has killed over 700 people. The response is being outpaced, with the WHO reporting 80% of new cases are from unknown transmission chains. The trial will test the drug as a post-exposure treatment for a virus that currently has no approved vaccine or therapy.

Outbreak transmission patterns

  • ▪Many newly reported Ebola deaths are of people who died in their communities without ever reaching a health facility
  • ▪As of July 13, 2026, the Bundibugyo Ebola virus outbreak has resulted in at least 1,926 confirmed cases and 702 deaths in Congo
  • ▪A U.S. citizen working for a humanitarian organization in Congo tested positive for the Ebola virus on July 11, 2026
  • ▪The World Health Organization stated that 80% of new Ebola cases in eastern Congo are from unknown chains of transmission
  • ▪The Africa Centres for Disease Control considers the current Ebola outbreak in Congo to be the fastest-growing on the continent

Response capacity challenges

  • ▪There is no approved treatment or vaccine for the rare Bundibugyo type of Ebola virus
  • ▪The World Health Organization has stated the Ebola outbreak is spreading faster than health officials can track and "continues to outpace the response efforts."
  • ▪The response to the Ebola outbreak has been hampered by a funding gap, attacks on health centers, ongoing conflict, and local community mistrust

Healthcare worker strike

  • ▪The strike prevented patients from accessing the treatment center for at least one day
  • ▪The striking healthcare workers agreed to return to work on July 14, 2026, on the condition that the government pays them within 72 hours
  • ▪On July 13, 2026, dozens of healthcare workers at an Ebola treatment center in northeast Congo went on strike over unpaid salaries and bonuses

Obeldesivir clinical trial

  • ▪Researchers in the Democratic Republic of Congo have begun a clinical trial of Gilead Sciences' experimental antiviral drug, obeldesivir
  • ▪A separate compassionate-use protocol will provide Gilead's injectable antiviral remdesivir to exposed children under 12 and pregnant or breastfeeding women
  • ▪The study aims to enroll about 1,000 people aged 12 and older who had high-risk exposure to a confirmed Ebola case within the previous five days
  • ▪The trial will assess if obeldesivir can work as a post-exposure treatment to reduce the risk of Ebola infection after contact with the virus

2 sources

Reuters
Congo begins trial of Gilead's experimental antiviral for Ebola Bundibugyo | Reuters
View source article
Statnews
Majority of new Ebola cases in eastern Congo are from unknown chains, as outbreak outpaces response
View source article

Story comments

Loading comments…

Topics

Infectious Disease and Outbreaks